Antithrombotic therapy in atrial fibrillation associated with valvular heart disease: a joint consensus document from the European Heart Rhythm Association (EHRA) and European Society of Cardiology Working Group on Thrombosis, endorsed by the ESC Working Group on Valvular Heart Disease, Cardiac Arrhythmia Society of Southern Africa (CASSA), Heart Rhythm Society (HRS), Asia Pacific Heart Rhythm Society (APHRS), South African Heart (SA Heart) Association and Sociedad Latinoamericana de Estimulacion Cardiaca y Electrofisiologia (SOLEACE)


Lip G. Y. H. , Collet J. P. , de Caterina R., Fauchier L., Lane D. A. , Larsen T. B. , ...Daha Fazla

EUROPACE, cilt.19, sa.11, ss.1757-1777, 2017 (SCI İndekslerine Giren Dergi) identifier identifier identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 19 Konu: 11
  • Basım Tarihi: 2017
  • Doi Numarası: 10.1093/europace/eux240
  • Dergi Adı: EUROPACE
  • Sayfa Sayıları: ss.1757-1777

Özet

Atrial fibrillation (AF) is a major worldwide public health problem, and AF in association with valvular heart disease (VHD) is also common. However, management strategies for this group of patients have been less informed by randomized trials, which have largely focused on 'non-valvular AF' patients.